reagents
Illumina Q4 Revenues Flat, 2020 Revenues Down 9 Percent
The company's fourth quarter and full-year revenues of $953 million and $3.24 billion, respectively, matched estimates released last month.
Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company
The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.
ERS Genomics, Applied StemCell Ink Commercialization Agreement for CRISPR Services, Reagents
Applied StemCell, based in the San Francisco Bay Area, will develop and sell CRISPR-based services and reagents under a license from ERS Genomics.
AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing
More than 70 percent of labs surveyed experienced supply chain interruptions, forcing them to validate three or more diagnostic testing methods.
Illumina Sues BGI Again, Alleging New CoolMPS Chemistry Infringes SBS Patents
According to the complaint, the allegedly infringing products include all those that use nucleotides with a 3’-O-azidomethyl blocking group.
Jan 17, 2020
Jan 16, 2020
Jul 11, 2019
Native Antigen Company Inks Distribution Deals
Jan 3, 2018
Maravai LifeSciences Acquires Glen Research
Jul 19, 2017
LGC Acquires Link Technologies
Jan 27, 2017
BioMerieux Recalls Molecular Assay Reagents
Oct 15, 2015
Kapa Bio Lands ISO Certification
Feb 25, 2014
Biofortuna Gets FDA OK for Freeze Dried HLA Kits
Oct 22, 2013